Beneficial Effects of Oral Carbon Monoxide on Doxorubicin‐Induced Cardiotoxicity

Background Doxorubicin and other anthracyclines are crucial cancer treatment drugs. However, they are associated with significant cardiotoxicity, severely affecting patient care and limiting dosage and usage. Previous studies have shown that low carbon monoxide (CO) concentrations protect against do...

詳細記述

書誌詳細

主要な著者:	Rodrigo W. Alves de Souza, Vanessa Voltarelli, David Gallo, Sidharth Shankar, Michael S. Tift, Mark Young, Edward Gomperts, Andrew Gomperts, Leo E. Otterbein
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wiley 2024-05-01
シリーズ:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
主題:	anthracyclines cancer carbon monoxide cardiotoxicity heme oxygenase‐1
オンライン･アクセス:	https://www.ahajournals.org/doi/10.1161/JAHA.123.032067
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!